The values ​​to follow today to Monday, September 19, 2022

(AOF) – Alstom

Alstom and the Romanian Railway Authority (ARF) have signed an amendment to their framework contract for the delivery of 17 additional Coradia Stream interregional trains as well as 15 years of associated maintenance services. These trains will be added to the first 20, ordered in March 2022, to create the first fleet of passenger trains delivered by Alstom in Romania.


Biocorp and Sanofi finalized the development of SoloSmart at the opening of the annual congress of the European Association for the Study of Diabetes (EASD) in Stockholm, Sweden. SoloSmart is compatible with SoloStar and Doublestar injection pens from the pharmaceutical group. This strategic step of the partnership validates a significant payment. More details will be given on September 29 (presentation of half-year results).


Last Friday, Bouygues, RTL Group, TF1 and the M6 ​​group announced that they were ending the planned merger of the TF1 and M6 groups, announced on May 17, 2021. This decision comes after the hearing of the parties by the College of the Authority of Competition, on September 5 and 6, to defend the interest and the necessity of the operation.

Office Veritas

Bureau Veritas has acquired Galbraith Laboratories Inc., an expert in advanced analytical solutions in North America. The transaction amount was not sent. Founded in 1950 and based in Knoxville (Tennessee, United States), the company employs approximately 70 people and generated revenue of €8 million in 2021. This acquisition created Bureau Veritas’ position in the chain of supply to consumer health and industrial chemistry.


Genfit has signed an exclusive agreement to acquire all of the shares and voting rights of Versantis AG, a private clinical-stage Swiss biotechnology company aimed at meeting the growing medical needs in the field of liver disease. This agreement includes an initial payment of 40 million Swiss francs due upon closing of the transaction as well as additional payments of up to 65 million Swiss francs conditional on positive Phase 2 results for VS-01 and VS-02 as well as regulatory approval of VS-01.

GenSight Biologics

GenSight Biologics announced the successful production of the first pilot batch (engineering run) incorporating improvements in the manufacturing process of Lumevoq, the company’s gene therapy for Leber’s hereditary optic neuropathy (LHON). This batch was the first to implement a series of corrective measures targeted by the company and its production partner in the United States in April this year, and relating to the strengthening of control of procedures as well as the establishment of reinforced on-site supervision.

Gorged Group

The industrial group will announce its results for the first half.

Hoffmann Green Cement Technologies

The low-carbon cement producer has published its second quarter sales and first half results.

Metabolic Explorer

Metabolic Explorer, leader in industrial fermentation allowing the manufacture of ingredients of natural origin intended for the animal nutrition, cosmetics and biopolymers markets, announced the finalization of the analysis of the life cycles of all its permitted acids allowing them to be positioned in a low-carbon offer, in order to meet the challenges of the animal sector in terms of decarbonization.


Nicox announced that the last visit (at 3 months) was completed by the last patients of the Mont Blanc Phase 3 clinical study of NCX 470 0.1% for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. A total of 691 patients were recruited into the study. NCX 470, Nicox’s lead drug candidate in clinical development, is a novel, potentially best-in-class nitric oxide (NO)-donating prostaglandin analog eye drop.

Flow Scale

The specialist in critical communications software solutions will announce its results for the first half.


The company specializing in in vitro diagnostics and Theranostics has published its results for the first half.


TotalEnergies has approved the final investment decision (FID) for the Fenix ​​gas development project, located 60 kilometers off the coast of Tierra del Fuego, in southern Argentina. The company, through its subsidiary Total Austral, operates the project with a 37.5% stake, in partnership with Wintershall DEA (37.5%) and Pan American Sur (25%).


From September 20 to 25, 2022, Valeo will present at the IAA Transportation show in Hanover, its technologies dedicated to the transport of goods and people. Together, they generated, for Valeo, a 50% increase in order prices compared to what had been recorded, four years earlier, during the previous edition of this European professional meeting. According to Valeo, the amount of these orders is in the billions of euros because the number of technologies offered by the group for commercial vehicles has also fallen by 50%.


Valneva SE, a vaccine company, and IDT Biologika have reached an agreement on the end of their collaboration on Covid-19 after deliveries of the vaccine material to Valneva and taking into account current order levels and existing stocks. In accordance with the commercial manufacturing agreement signed in November 2021 for the manufacture of the vaccine, IDT Biologika produced the substance of VLA 2001 in bulk at its biosafety level 3 facilities in Germany and Valneva purchased the batches produced by IDT at this day.


Wendel’s Supervisory Board, which met on September 16, 2022 under the chairmanship of Nicolas ver Hulst, appointed Laurent Mignon as a member and Chairman of Wendel’s Management Board, effective January 1, 2023 at the latest. He will succeed André François- Poncet, Chairman of Wendel’s Management Board, who proved to perform his duties until his effective arrival from Wendel. Wendel’s Management Board will then be made up of Laurent Mignon, its Chairman, and David Darmon, Chief Executive Officer and member of the Management Board since 2019.

Leave a Comment